HOXB5 and hepatocellular carcinoma: Interestingly, treatment of HCC cells with either of the small molecule inhibitors BLU-554 or SB265610, which respectively inhibit FGFR4 or CXCL1, significantly impaired the metastatic cascade initiated by the HoxB5 overexpression [96].